Published in Br J Radiol on August 07, 2015
Tracking of iron-labeled human neural stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson's disease. Neural Regen Res (2016) 0.84
Cytocompatible and multifunctional polymeric nanoparticles for transportation of bioactive molecules into and within cells. Sci Technol Adv Mater (2016) 0.75
Rhodamine bound maghemite as a long-term dual imaging nanoprobe of adipose tissue-derived mesenchymal stromal cells. Eur Biophys J (2016) 0.75
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation (2005) 4.20
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol (2010) 4.03
Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation (2005) 3.61
In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol (2009) 2.85
In vivo detection of single cells by MRI. Magn Reson Med (2006) 2.75
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med (2005) 2.38
Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation (2008) 2.37
Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation (2008) 2.22
Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant (2008) 2.03
Tracking neural stem cells in patients with brain trauma. N Engl J Med (2006) 1.95
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev (2010) 1.88
Cell-based therapeutics: the next pillar of medicine. Sci Transl Med (2013) 1.83
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology (2005) 1.79
Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation (2009) 1.73
Cellular magnetic resonance imaging: current status and future prospects. Expert Rev Med Devices (2006) 1.71
Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed (2010) 1.60
CEST: from basic principles to applications, challenges and opportunities. J Magn Reson (2012) 1.59
Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging (2004) 1.56
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol (2002) 1.53
Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology (2012) 1.51
(19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol (2010) 1.49
Cell tracking with optical imaging. Eur Radiol (2008) 1.47
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol (2004) 1.44
Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc (2011) 1.41
Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn Reson Med (2006) 1.38
Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine (2014) 1.34
Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics (2013) 1.33
Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells Dev (2007) 1.31
Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ Res (2011) 1.30
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging (2012) 1.29
Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28
In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed (2013) 1.25
The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed (2007) 1.23
Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy (2010) 1.23
Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI. Biomaterials (2012) 1.22
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage (2008) 1.20
Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation (2010) 1.19
Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials (2010) 1.18
Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J Neuroimmunol (2005) 1.17
Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med (2012) 1.16
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol (2011) 1.16
Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med (2014) 1.15
Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy (2009) 1.14
Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn Reson Med (2010) 1.14
In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One (2009) 1.12
Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur Heart J (2006) 1.12
FDA oversight of cell therapy clinical trials. Sci Transl Med (2012) 1.12
Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small (2010) 1.12
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med (1993) 1.11
Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle. J Vis Exp (2011) 1.09
Noninvasive molecular imaging using reporter genes. J Nucl Med (2013) 1.08
Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides. PLoS One (2011) 1.07
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. Stem Cells Transl Med (2013) 1.07
mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo. Stem Cells (2013) 1.07
Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res (1992) 1.06
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One (2009) 1.06
MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed (2012) 1.05
Labeling cells for in vivo tracking using (19)F MRI. Biomaterials (2012) 1.04
Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther (2010) 1.03
Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI. Cell Transplant (2011) 1.02
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett (2012) 1.02
Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond) (2013) 1.01
Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials (2009) 1.01
A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer (2010) 1.01
Manganese-guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability. Magn Reson Med (2009) 1.00
Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. Nanoscale (2011) 1.00
Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1 and T2 relaxivity. Magn Reson Med (2009) 0.98
Gadolinium hexanedione nanoparticles for stem cell labeling and tracking via magnetic resonance imaging. Biomaterials (2010) 0.98
A decade of cell therapy clinical trials (2000-2010). Regen Med (2012) 0.97
Commercial nanoparticles for stem cell labeling and tracking. Theranostics (2013) 0.97
The survival of engrafted neural stem cells within hyaluronic acid hydrogels. Biomaterials (2013) 0.97
Highly efficient paramagnetic labelling of embryonic and neuronal stem cells. Eur J Nucl Med Mol Imaging (2003) 0.96
Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Contrast Media Mol Imaging (2012) 0.95
In vivo MRI visualization of different cell populations labeled with PARACEST agents. Magn Reson Med (2012) 0.95
A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging. Mol Imaging Biol (2011) 0.94
In vivo quantitative assessment of cell viability of gadolinium or iron-labeled cells using MRI and bioluminescence imaging. Contrast Media Mol Imaging (2013) 0.93
Nanoparticle-based chemical exchange saturation transfer (CEST) agents. NMR Biomed (2013) 0.92
The role of cell-released microvesicles in the intercellular transfer of magnetic nanoparticles in the monocyte/macrophage system. Biomaterials (2010) 0.92
In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA (2005) 0.92
Mesenchymal stem cells reduce pain but not degenerative changes in a mono-iodoacetate rat model of osteoarthritis. J Orthop Res (2014) 0.91
Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF. PLoS One (2014) 0.91
Tracking the fate of stem cell implants with fluorine-19 MRI. PLoS One (2015) 0.90
Protection of islet grafts through transforming growth factor-β-induced tolerogenic dendritic cells. Diabetes (2013) 0.89
Labelling of mammalian cells for visualisation by MRI. Eur Radiol (2009) 0.88
Ultrasmall superparamagnetic iron oxide nanoparticle prelabelling of human neural precursor cells. Biomaterials (2014) 0.87
Nanoparticles for cancer imaging: The good, the bad, and the promise. Nano Today (2013) 0.87
Multifunctional core–shell silica nanoparticles for highly sensitive (19)F magnetic resonance imaging. Angew Chem Int Ed Engl (2014) 0.85
High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs. ACS Nano (2013) 0.85
Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging. Sci Rep (2013) 0.85
Variability in contrast agent uptake by different but similar stem cell types. Int J Nanomedicine (2013) 0.85
Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages. Int J Nanomedicine (2012) 0.85
Cell tracking in cardiac repair: what to image and how to image. Eur Radiol (2011) 0.84
Science to practice: can stem cells be labeled inside the body instead of outside? Radiology (2013) 0.84
The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. Biomaterials (2013) 0.84
Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process. Int J Nanomedicine (2014) 0.84